Wall Street analysts will be watching closely when Cardinal Health, Inc. (NYSE:CAH) reports its quarterly earnings next, which is scheduled for Thu 2 May (In 73 Days). Looking at the latest analyst forecasts, the current earnings-per-share (EPS) consensus estimate is sitting at $1.22 per share. In the preceding quarter, the company reportedly generated EPS of $1.29 per share of its common stock. Looking at profitability indicators, this organization has an operating margin of 0.60%, a profit margin of 0.00% and a gross margin of 5.00%.
Speaking of Wall Street analysts, a number of market experts at top investment banks have recently posted their updated ratings on shares of Cardinal Health, Inc. (NYSE:CAH). Most recently, on January 17th, 2019, UBS Initiated a Neutral rating. Before that, on November 16th, 2018, Leerink Partners Downgrade to Mkt Perform. Leerink Partners Upgrade a Outperform rating on April 24th, 2018, Argus Upgrade an Buy rating on April 2nd, 2018, and Barclays Initiated a Equal Weight rating on March 8th, 2018.
At its current price point, combined with the fact that this company has 298.12M shares outstanding, the current market capitalization sits at 16.54B. In the last trading day, 3,609,010 shares of Cardinal Health, Inc. were traded, which compares to its usual volume of about 3.64M shares per day of trading.
If we compare this company’s current price to its recent pricing activity, we can see that the price has changed by $2.81 in the past five trading days, resulting in a percentage change of +5.34% and a moving average of 54.75. In the past 20 days, its price changed by $7.31 (which is +15.18%) and the stock’s moving average was 51.13. Looking back a full 50 days, shares of CAH changed by -$0.72 (which is -1.28%) and demonstrated a moving average of 49.22.
Staying in the same analytical area, this company’s stock has demonstrated a 9-day Stochastic %K score of 95.87%, a 14-day Stochastic %K score of 96.47% and a 20-day Stochastic %K score of 96.62%. Using a similar metric, Cardinal Health, Inc. (CAH) shares showed a Stochastic %D of 94.73% over the past 9 days, a Stochastic %D score of 95.01% over the last 14 days, and a 20-day Stochastic %D of 95.58%. Meanwhile, this stock’s MACD Oscillator was 1.83 over the past 9 days, 3.27 over the past two weeks, and 4.22 in the last 20 days.
As recent trading data suggests, this company’s shares have been hovering close to the $55.48 level. Over the past 12 months, this stock has experienced a high price of $73.23 and a low of $42.17. Top market experts pay heightened attention to a stock as it is getting closer to a notable historic high price or low price.
The Vanguard Group Inc purchased more shares of this company during the last fiscal quarter, as we can observe in the latest corresponding filing from Cardinal Health, Inc. (NYSE:CAH) with the Securities and Exchange Commission (SEC). This specific major shareholder, at the end of the quarter, held 28,512,166 shares of the company’s stock following the addition of 944,659 to this investor’s holdings during the three-month period. This share count represents that The Vanguard Group Inc now held 9.57% stake in Cardinal Health, Inc. (CAH)’s shares.
Just in the most recent trading day, Cardinal Health, Inc. (NYSE:CAH) experienced a high price of $55.98 and low point of $55.36. At the end of the last trading session, this stock was at 55.48 per share, following a gain of $0.4, or -0.04% during the full day.